Teva Pharmaceutical Industries Limited (TEV) — Long-term Investment Intensity
Teva Pharmaceutical Industries Limited (TEV) has a Long-term Investment Intensity of 0.1% as of December 2018. Long-term investments of €61.00 Million represent 0.1% of total assets of €60.68 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Teva Pharmaceutical Industries Limited liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Teva Pharmaceutical Industries Limited Long-term Investment Intensity (2015–2018)
This chart shows how Teva Pharmaceutical Industries Limited's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of December 2018, the intensity stands at 0.1%, reflecting long-term investments of €61.00 Million against total assets of €60.68 Billion EUR. For the complete balance sheet picture, see Teva Pharmaceutical Industries Limited assets under control.
Annual Long-term Investment Intensity for Teva Pharmaceutical Industries Limited (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Teva Pharmaceutical Industries Limited from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read how much debt does Teva Pharmaceutical Industries Limited carry for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.1% | €61.00 Million | €60.68 Billion | ▼ 0.0 pp |
| 2017 | 0.1% | €83.00 Million | €70.61 Billion | ▼ -0.2 pp |
| 2016 | 0.3% | €283.00 Million | €92.89 Billion | ▼ -2.4 pp |
| 2015 | 2.7% | €1.45 Billion | €54.23 Billion | — |